AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Design and Implementation of the Pediatric Liver Transplantation Biobank

Recruitingn/aAges 1 Month - 18 YearsAllChildren's Hospital of Chongqing Medical Universiโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of the pediatric liver transplant biobank is to systematically collect clinical specimens from pediatric end-stage liver disease. It is expected to contribute to the research and development of paediatric end-stage liver disease in the future.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Children diagnosed with end-stage liver disease. 2. Liver transplantation in our hospital. 3. informed patient consent. 4. long-term follow-up in our hospital. Exclusion Criteria: No fixed contact information, difficult to follow up the patients.
๐Ÿ’Š

What it tests

  • No intervention
๐Ÿ“

Where

1 site
Children's Hospital of Chongqing Medical University
Chongqing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy